MARKET

OPTN

OPTN

Optinose
NASDAQ
9.15
+0.01
+0.11%
After Hours: 9.10 -0.05 -0.55% 19:52 03/28 EDT
OPEN
9.15
PREV CLOSE
9.14
HIGH
9.17
LOW
9.13
VOLUME
93.31K
TURNOVER
--
52 WEEK HIGH
24.60
52 WEEK LOW
4.815
MARKET CAP
92.64M
P/E (TTM)
-4.3142
1D
5D
1M
3M
1Y
5Y
1D
Optinose Reports Revenue Growth Amid Financial Challenges
TipRanks · 1d ago
Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More
NASDAQ · 3d ago
OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates
NASDAQ · 3d ago
Form 10-K for the fiscal year ended December 31, 2024
Press release · 3d ago
OptiNose GAAP EPS of -$0.03 beats by $0.76, revenue of $22.42M beats by $1.6M
Seeking Alpha · 3d ago
OptiNose Inc. Q4 Loss Decreases, Beats Estimates
NASDAQ · 3d ago
Press Release: Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
Dow Jones · 3d ago
*Optinose 4Q Rev $22.4M >OPTN
Dow Jones · 3d ago
More
About OPTN
More
OptiNose, Inc. is a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists. The Company's product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing its Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). XHANCE combines the EDS with a liquid formulation of fluticasone propionate, a well-characterized, second-generation corticosteroid. XHANCE is designed to deliver medication into the high and deep regions of the nasal passages where both nasal polyps and inflamed and swollen membranes can obstruct normal sinus ventilation and drainage. The Company has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to offer better drug deposition.
Recently
Symbol
Price
%Change

Webull offers OptiNose Inc stock information, including NASDAQ: OPTN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPTN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPTN stock methods without spending real money on the virtual paper trading platform.